The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30.

Here’s the latest list of major oversold players in this sector, having an RSI near or below 30.

BioVie Inc. (NASDAQ:BIVI)

• BioVie presented data for NE3107 at 2023 International Congress of Parkinson's Disease and Movement Disorders. The company’s stock has a 52-week low of $1.96 .
• RSI Value: 26.01
• BIVI Price Action: Shares of BioVie fell around 1% to close at $3.06 on Tuesday.

23andMe Holding Co. (NASDAQ:ME)

• 23andMe announced received FDA 510(k) clearance to expand its existing BRCA1/BRCA2 (Selected Variants) Genetic Health Risk Report. It has a 52-week low of $0.9870.
• RSI Value: 29.59
• ME Price Action: Shares of 23andMe Holding fell 8% to close at $1.03 on Tuesday.

Singular Genomics Systems, Inc. (NASDAQ:OMIC)

Galera Therapeutics, Inc. (NASDAQ:GRTX)

iSpecimen Inc. (NASDAQ:ISPC)

• iSpecimen launched new virtual cancer sequencing procurement program. The company has a 52-week low of $0.6818.
• RSI Value: 21.05
• ISPC Price Action: Shares of iSpecimen fell 1.5% to close at $0.7003 on Tuesday.

Read More: Investor Sentiment Improves; Dow Falls Nearly 200 Points